Search
Now showing items 1-2 of 2
Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
(BioMed Central, 2013-06-19)
Background
The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth Factor Receptor (EGFR) is well validated as a primary contributor of glioma initiation and progression. Nimotuzumab is a ...
Validation of a Spanish version of the Revised Fibromyalgia Impact Questionnaire (FIQR)
(Biomed Central, 2013)
[EN]The Revised version of the Fibromyalgia
Background
The Revised version of the Fibromyalgia Impact Questionnaire (FIQR) was published in 2009. The aim of this study was to prepare a Spanish version, and to assess its ...